Guiding policy decisions for genetic screening: developing a systematic and transparent approach
- PMID: 20051674
- DOI: 10.1159/000272898
Guiding policy decisions for genetic screening: developing a systematic and transparent approach
Abstract
With the ever-widening gap between what is technologically possible and services available, jurisdictions around the world are faced with complex decisions regarding the introduction and expansion of genetic screening programs. A series of literature reviews and consultations with stakeholders and experts led to the development of a decision support guide for genetic screening policy-making. This involved establishing a preliminary list of core criteria synthesized from the growing literature on genetic screening, which was then transformed through a series of consultations into a more elaborate decision guide. Although certain perennial challenges in genetic screening policy-making remain, the decision support guide aims to promote a fair and evidence-informed process that makes explicit the ethical dilemmas often inherent to such policy decisions.
Copyright © 2009 S. Karger AG, Basel.
Similar articles
-
Genetic screening: a conceptual framework for programmes and policy-making.J Health Serv Res Policy. 2010 Apr;15(2):90-7. doi: 10.1258/jhsrp.2009.009084. Epub 2010 Feb 22. J Health Serv Res Policy. 2010. PMID: 20176664 Review.
-
Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.Health Policy Plan. 2012 May;27 Suppl 2:ii27-38. doi: 10.1093/heapol/czs037. Health Policy Plan. 2012. PMID: 22513730
-
Addressing the theoretical, practical and ethical challenges inherent in prospective health policy analysis.Health Policy Plan. 2008 Sep;23(5):351-60. doi: 10.1093/heapol/czn026. Epub 2008 Jul 29. Health Policy Plan. 2008. PMID: 18664524
-
Evidence-based public health: what does it offer developing countries?J Public Health (Oxf). 2005 Jun;27(2):215-21. doi: 10.1093/pubmed/fdi024. Epub 2005 Apr 8. J Public Health (Oxf). 2005. PMID: 15820994
-
[Development and dilemmas of health impact assessment].Przegl Epidemiol. 2008;62(3):623-32. Przegl Epidemiol. 2008. PMID: 19108527 Review. Polish.
Cited by
-
Australian public perspectives on genomic newborn screening: which conditions should be included?Hum Genomics. 2024 May 8;18(1):45. doi: 10.1186/s40246-024-00611-x. Hum Genomics. 2024. PMID: 38720401 Free PMC article.
-
Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?Pharmgenomics Pers Med. 2023 Jul 1;16:681-691. doi: 10.2147/PGPM.S376083. eCollection 2023. Pharmgenomics Pers Med. 2023. PMID: 37415831 Free PMC article. Review.
-
Genetic screening: A primer for primary care.Can Fam Physician. 2010 Apr;56(4):333-9. Can Fam Physician. 2010. PMID: 20393090 Free PMC article. Review.
-
Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures.Int J Neonatal Screen. 2023 Jun 22;9(3):35. doi: 10.3390/ijns9030035. Int J Neonatal Screen. 2023. PMID: 37489488 Free PMC article. Review.
-
Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany.Orphanet J Rare Dis. 2011 Jun 20;6:44. doi: 10.1186/1750-1172-6-44. Orphanet J Rare Dis. 2011. PMID: 21689452 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous